Maculopapular eruption to rivastigmine's transdermal patch application and successful oral desensitization.
Makris
M
M
Allergy Unit, Attikon University Hospital, University of Athens, Athens, Greece. mmakris.allergy@gmail.com
Koulouris
S
S
Koti
I
I
Aggelides
X
X
Kalogeromitros
D
D
D000279:Administration, Cutaneous; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000209:etiology / Q000517:prevention & control*; D005076:Exanthema / Q000139:chemically induced* / Q000517:prevention & control; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D048448:Phenylcarbamates / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D000068836:Rivastigmine; D012882:Skin Tests
D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D000068836:Rivastigmine